← Search organizationsOpenPolis
FDANonrulemakingFDA-2013-P-1398

Who commented on this docket

Require That a Biosimilar be Identified by the Same International Nonproprietary Name as the Reference Product

3 organizations filed 3 public comments on Require That a Biosimilar be Identified by the Same International Nonproprietary Name as the Reference Product, at the Food and Drug Administration.

Organizations
3
Comments
3
RIN
—
Comment window
—

Commenters (3)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.

Who Commented on Require That a Biosimilar be Identified by the Same International Nonproprietary Name as the Reference Product (FDA-2013-P-1398) | OpenPolis